⚡ Zaynich® Delivers 97% Efficacy!

• 💊 Therapy: Zaynich® (Zidebactam/Cefepime, WCK 5222)

• 🌟 Result: Over 97% efficacy against meropenem-resistant Gram-negative pathogens

• 🏥 Scope: Severe infections, including HABP, VABP, BSI, cIAI, and cUTI

A groundbreaking step in combating carbapenem-resistant infections! 🚀